Role of the funding source
INFLUENZA
Principal funding for this Phase I trial was provided by the Australian Government's Medical Research Future Fund (MRFF). Additional funding for lab and facility support was provided by the National Health & Medical Research Council of Australia, and philanthropic funding from the Jack Ma Foundation and IFM. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Govt Dept of Health. Duke-NUS authors were supported by the Singapore National Medical Research Council. None of these funders had any input into, review or influence on the conduct and reporting of this study.